Skip to main content

Zepp Health Corp

corporate_fare Company Profile

Zepp Health Corp

ZEPP·NYSE·Technology·CIK 0001720446

We are a global smart wearable and health technology leader with operations in Europe, the U.S., and Asia. We offer three consumer brands: Amazfit, Zepp Clarity, and Zepp Aura. Amazfit provides smartwatches and wearables for various fitness levels and lifestyles, with a range of product offerings and full price-range coverage. Zepp Clarity offers discreet, AI-powered hearing aids to address hearing loss. Zepp Aura delivers personalized, AI-generated soundscapes designed to improve sleep and relaxation. Our proprietary digital health management platform includes the Zepp OS, AI chips, biometric sensors, hardware, and specialized health data algorithms. This platform provides cloud-based insights and guidance 24/7. Our proprietary HuangShan 3 chip and biosensors utilize an open-source RISC-V architecture. We have incorporated generative AI solutions, including Zepp Flow, Zepp Coach, Zepp Aura, and Food Log features. Our devices offer industry-leading GPS and heart-rate accuracy, long battery life, extended GPS operation time, advanced free offline maps, and comprehensive workout models with professional-level data for activities such as golf and free diving. We maintain an integrated device, chip, and cloud strategy. We comply with GDPR and HIPAA frameworks, and data is stored on AWS infrastructure. We also apply our AI expertise to industrial medical imaging technologies, providing big data and analytics capabilities for medical and diagnostics care service providers.

Zepp Health Corp (NYSE:ZEPP) is a publicly traded company in the Technology sector. Wiseek monitors ZEPP SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Zepp Health Reports Strong Q1 Revenue Growth, Narrowed Loss, and Positive Q2 Guidance
  • Zepp Health Projects Q2 Revenue Between $63M and $68M
  • Zepp Health Reports Strong 41.8% Revenue Growth and Halves Net Loss in 2025 Annual Report
  • Zepp Health Reports Strong Q4 & FY25 Revenue Growth, Record Margins, and Narrowed Losses; Issues Positive Q1 2026 Outlook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$258.9M
Net Income
-$40.07M
Diluted EPS
-$0.16
Op. Cash Flow
-$25.69M
Free Cash Flow
-$26.21M
Gross Profit
$99.19M
Operating Income
-$29.23M
Cash & Equivalents
$57.05M
Total Debt
$59.48M
Debt / Equity
0.28×
Net Margin
-15.5%
Shares Outstanding
254.43M sh
Source: 20-F · filed 2026-04-24 · accession 0001104659-26-048127

Insider Transactions

ZEPP files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with Z →
$4.68 -0.01% today
52-week range · as of 2026-06-09 $2.25 – $61.85
Market cap
$68.85M
Volume
149.7K (0.8× avg)
3-mo avg 182K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ZEPP - Latest Insights

ZEPP
Jun 09, 2026, 6:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.41
Real-time Price: $4.68 info
Change: -$1.73 (-27%) info
Market Cap: $68.851M info
ZEPP
Jun 08, 2026, 9:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $6.34
Real-time Price: $4.68 info
Change: -$1.66 (-26%) info
Market Cap: $68.851M info
ZEPP
Apr 24, 2026, 7:26 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $16.52
Real-time Price: $4.68 info
Change: -$11.84 (-72%) info
Market Cap: $68.851M info
ZEPP
Mar 16, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $18.80
Real-time Price: $4.68 info
Change: -$14.12 (-75%) info
Market Cap: $68.851M info